Paper Details

  1. Home
  2. Paper Details

[Radically resected pancreatic cancer and adjuvant treatment. A review of the literature].

Author: BarzottiEleonora, DrudiFabrizio, FantiniManuela, GianniLorenzo, GiulianiJacopo, LottiNadia, RavaioliAlberto, RidolfiClaudio, SantelmoCarlotta, TamburiniEmiliano, TassinariDavide

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Adjuvant therapy is a standard treatment for patients who have had pancreatic cancer surgery. This study will review the evidence on the use of chemotherapy and chemoradiotherapy after surgery, focusing on the effectiveness and toxicity of different treatment options.
Paper Details　
Original Abstract of the Article :
Adjuvant therapy represents the gold standard treatment for radically resected pancreatic cancer. Results from randomized clinical trials confirmed the efficacy of adjuvant therapy for pancreatic cancer but did not define what is the "right choice" in terms of type of antiblastic drug (among gemcita...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1701/1241.13711

データ提供：米国国立医学図書館（NLM）

Radically Resected Pancreatic Cancer and Adjuvant Treatment: A Review of the Literature

This comprehensive review examines the current state of adjuvant therapy for radically resected pancreatic cancer, a challenging and often aggressive disease. The study delves into the efficacy and toxicity of adjuvant chemotherapy and chemoradiotherapy, drawing insights from a systematic review of existing literature. The authors aim to clarify the best treatment options regarding the types of antiblastic drugs, the role of polychemotherapy, and the value of chemoradiotherapy, all in the context of improving overall survival and disease-free survival.

Improving Survival Rates for Pancreatic Cancer: A Journey Through the Literature

The review underscores the importance of adjuvant therapy in radically resected pancreatic cancer. While the study does not provide definitive answers regarding the ideal treatment regimen, it highlights the benefits of adjuvant therapy in terms of overall survival and disease-free survival. The comprehensive analysis of existing literature provides valuable guidance for clinicians in their treatment decisions for this challenging disease.

Navigating the Treatment Landscape: Hope in the Face of a Difficult Diagnosis

Understanding the efficacy and toxicity of various treatment options for pancreatic cancer is crucial for making informed clinical decisions. This review serves as a valuable tool for clinicians, providing a comprehensive overview of the current state of knowledge. It highlights the need for ongoing research to further optimize treatment strategies and improve outcomes for patients with this challenging disease.

Dr.Camel's Conclusion

This review offers a comprehensive overview of the current literature regarding adjuvant therapy for radically resected pancreatic cancer. It highlights the importance of tailoring treatment strategies to each individual patient based on the specific characteristics of their disease and their overall health. Like a camel traversing a difficult terrain, researchers are always seeking new paths to improve survival rates and minimize the impact of this challenging disease. The search for optimal treatment continues, with the ultimate goal of improving the quality of life and survival rates for patients with pancreatic cancer.
Date :
  1. Date Completed 2013-06-27
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

23535964

DOI: Digital Object Identifier

10.1701/1241.13711

Related Literature

Article Analysis
・Effective treatment of pancreatic cancer
SNS
PICO Info
in preparation
Languages

Italian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.